Avastin (bevacizumab) - Angiogenesis Inhibitor and Cancer Therapy

Print-Icon
Print

To meet the growing demand for licensed products and new drugs coming on stream, Genentech is increasing production capacity.
 
«Back

  • Angiogenesis inhibitor
  • Angiogenesis Inhibitors
  • Tumour angiogenesis
  • Cross-section of solid tumour
  • Roche R&D Centre, Basle
  • Drug development Process
  • Genentech


| 1 | 2 | 3 | 4 | 5 | 6 | 7 |

Browse More Images - Return to Project




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
Features
White Papers
Jobs & Careers
Industry News
Gallery
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development